BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10396195)

  • 1. Efficacy of nedocromil 2% versus fluorometholone 0.1%: a randomised, double masked trial comparing the effects on severe vernal keratoconjunctivitis.
    Tabbara KF; al-Kharashi SA
    Br J Ophthalmol; 1999 Feb; 83(2):180-4. PubMed ID: 10396195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nedocromil sodium eye drops are more effective than sodium cromoglycate eye drops for the long-term management of vernal keratoconjunctivitis.
    Verin PH; Dicker ID; Mortemousque B
    Clin Exp Allergy; 1999 Apr; 29(4):529-36. PubMed ID: 10202368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double blind placebo controlled group comparative study of ophthalmic sodium cromoglycate and nedocromil sodium in the treatment of vernal keratoconjunctivitis.
    el Hennawi M
    Br J Ophthalmol; 1994 May; 78(5):365-9. PubMed ID: 8025071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of lodoxamide, disodium cromoglycate and fluorometholone on tear leukotriene levels in vernal keratoconjunctivitis.
    Akman A; Irkeç M; Orhan M
    Eye (Lond); 1998; 12 ( Pt 2)():291-5. PubMed ID: 9683957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical cyclosporine in vernal keratoconjunctivitis.
    Bleik JH; Tabbara KF
    Ophthalmology; 1991 Nov; 98(11):1679-84. PubMed ID: 1800929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of low-dose, topical mitomycin-C in the treatment of severe vernal keratoconjunctivitis.
    Akpek EK; Hasiripi H; Christen WG; Kalayci D
    Ophthalmology; 2000 Feb; 107(2):263-9. PubMed ID: 10690822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with Tilavist: an overview of efficacy and safety.
    Kjellman NI; Stevens MT
    Allergy; 1995; 50(21 Suppl):14-22; discussion 34-8. PubMed ID: 7785746
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of indomethacin 0.1% and fluorometholone 0.1% on conjunctival inflammation following chronic application of antiglaucomatous drugs.
    Baudouin C; Nordmann JP; Denis P; Creuzot-Garcher C; Allaire C; Trinquand C
    Graefes Arch Clin Exp Ophthalmol; 2002 Nov; 240(11):929-35. PubMed ID: 12486516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical 2% cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis.
    Kiliç A; Gürler B
    Can J Ophthalmol; 2006 Dec; 41(6):693-8. PubMed ID: 17224949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of nedocromil sodium 2% eyedrops on clinical symptoms and tear fluid cytology of patients with vernal conjunctivitis.
    Bonini S; Barney NP; Schiavone M; Centofanti M; Berruto A; Bonini S; Allansmith MR
    Eye (Lond); 1992; 6 ( Pt 6)():648-52. PubMed ID: 1337745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-masked comparison of 0.1% tacrolimus ointment and 2% cyclosporine eye drops in the treatment of vernal keratoconjunctivitis in children.
    Labcharoenwongs P; Jirapongsananuruk O; Visitsunthorn N; Kosrirukvongs P; Saengin P; Vichyanond P
    Asian Pac J Allergy Immunol; 2012 Sep; 30(3):177-84. PubMed ID: 23156846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tear tryptase in vernal keratoconjunctivitis.
    Tabbara KF
    Arch Ophthalmol; 2001 Mar; 119(3):338-42. PubMed ID: 11231766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preservative-free diclofenac sodium 0.1% for vernal keratoconjunctivitis.
    D'Angelo G; Lambiase A; Cortes M; Sgrulletta R; Pasqualetti R; Lamagna A; Bonini S
    Graefes Arch Clin Exp Ophthalmol; 2003 Mar; 241(3):192-5. PubMed ID: 12644942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitis.
    Sharma A; Gupta R; Ram J; Gupta A
    Indian J Ophthalmol; 1997 Sep; 45(3):177-80. PubMed ID: 9475021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of topical tacrolimus 0.03% in the management of vernal keratoconjunctivitis: a non-randomized controlled clinical trial.
    Eltagoury M; Abou Samra W; Ghoneim E
    Med Hypothesis Discov Innov Ophthalmol; 2022; 11(2):52-63. PubMed ID: 37641784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes.
    Vichyanond P; Pacharn P; Pleyer U; Leonardi A
    Pediatr Allergy Immunol; 2014 Jun; 25(4):314-22. PubMed ID: 24438133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of cyclosporine eyedrops in vernal keratoconjunctivitis.
    Pucci N; Novembre E; Cianferoni A; Lombardi E; Bernardini R; Caputo R; Campa L; Vierucci A
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):298-303. PubMed ID: 12269651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative evaluation of topical pranoprofen and fluorometholone in cases with chronic allergic conjunctivitis.
    Li Z; Mu G; Chen W; Gao L; Jhanji V; Wang L
    Cornea; 2013 May; 32(5):579-82. PubMed ID: 23023407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of supratarsal dexamethasone versus triamcinolone injection in recalcitrant vernal keratoconjunctivitis.
    Saini JS; Gupta A; Pandey SK; Gupta V; Gupta P
    Acta Ophthalmol Scand; 1999 Oct; 77(5):515-8. PubMed ID: 10551290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe vernal keratoconjunctivitis requiring trabeculectomy with mitomycin C for corticosteroid-induced glaucoma.
    Ang M; Ho CL; Tan D; Chan C
    Clin Exp Ophthalmol; 2012; 40(4):e149-55. PubMed ID: 21575117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.